Characterization of gene expression changes associated with MNNG, arsenic, or metal mixture treatment in human keratinocytes: Application of cDNA microarray technology

Environmental Health Perspectives

Volumn 110, Issue SUPPL. 6, 2002, Pages 931-941

  Bae, Dong Soon ^a   Hanneman, William H ^a   Yang, Raymond S H ^a   Campain, Julie A ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Arsenic; cDNA microarray; Cell transformation; Chemical carcinogenesis; Gene expression; Human keratinocytes; Metal mixture; Molecular markers

Indexed keywords

ARSENIC; CADMIUM; CHROMIUM; COMPLEMENTARY DNA; LEAD; METAL DERIVATIVE; METHYLNITRONITROSOGUANIDINE; MITOGEN ACTIVATED PROTEIN KINASE; XENOBIOTIC AGENT;

CELL CYCLE; CELL LINE; CELL TRANSFORMATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA MICROARRAY; DNA REPAIR; ENVIRONMENTAL EXPOSURE; ENZYME INHIBITION; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC TOXICOLOGY; HUMAN; HUMAN CELL; KERATINOCYTE; LONG TERM EXPOSURE; MALIGNANT TRANSFORMATION; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE;

EID: 12244304220     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.02110s6931     Document Type: Review

References (47)

1. Chen C-J, Chen CW, Wu M-M, Kuo T-L. Cancer potential in liver, lung, bladder, and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 66:888-892. (1992).
2. Tseng WP. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect 19:109-119 (1977).
3. ATSDR. 1997 CERCLA Priority List of Hazardous Substances That Will Be the Subjects of Toxicological Profile & Support Document. Atlanta, GA:Agency for Toxic Substances and Disease Registry, 1997.
4. De Rosa CT, Johnson BL, Fay M, Hansen H, Mumtaz MM. Public health implications of hazardous waste sites: findings, assessment, and research. Food Chem Toxicol 34:1131-1138 (1996).
5. Fay M, Mumtaz MM. Development of a priority list of chemical mixtures occuring at 1188 hazardous waste sites using the HazDat database. Food Chem Toxicol 34:1163-1165 (1996).
6. Goyer RA. Toxic effects of metals. In: Casarett & Doull's Toxicology: The Basic Science of Poisons (Klaasen CD, ed). New York:McGraw-Hill, 1996;691-736.
7. Snow ET. Metal carcinogenesis: mechanistic implications. Pharmacol Ther 53:31-65 (1992).
8. Diaz-Barriga F, Llamas E, Mejia JJ, Carrizales L, Santoyo ME, Vega-Vega L, Yanez L. Arsenic-cadmium interaction in rats. Toxicology 64:191-203 (1990).
9. Elsenhans B, Schmolke K, Kolb K, Stokes J, Forth W. Metal-metal interactions among dietary toxic and essential trace elements in the rat. Ecotoxicol Environ Saf 14:275-287 (1987).
10. Nordberg GF, Anderson O. Metal interactions in carcinogenesis: enhancement, inhibition. Environ Health Perspect 40:65-81 (1981).
11. Bae DS, Gennings C, Carter WH Jr, Yang RSH, Campain JA. Toxicological interactions among arsenic, cadmium, chromium, and lead in human keratinocytes. Toxicol Sci 63:132-142 (2001).
12. Chen C-J, Chuang Y-C, Lin T-M, Wu H-Y. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancer. Cancer Res 45:5895-5899 (1985).
13. Nriagu JO. Arsenic in the Environment. Part II: Human Health and Ecosystem Effects. New York:Wiley, 1994.
14. Cohen MD, Kargacin CB, Klein CB, Costa M. Mechanisms of chromium carcinogenicity and toxicology. Crit Rev Toxicol 23:255-281 (1993).
15. Germolec DR, Spalding J, Boorman GA, Wilmer JL, Yoshida T, Simeonova PP, Bruccoleri A, Kayama F, Gaido K, Tennant R, et al. Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors. Mutat Res 386:209-218 (1997).
16. Germolec DR, Yoshida T, Gaido K, Wilmer JL, Simeonova PP, Kayama F, Burleson F, Dong W, Lang RW, Luster MI. Arsenic induces overexpression of growth factors in human keratinocytes. Toxicol Appl Pharmacol 141:308-318 (1996).
17. Kachinskas DJ, Qin Q, Phillips MA, Rice RA. Arsenate suppression of human keratinocyte programming. Mutat Res 386:253-261 (1997).
18. Ye J, Zhang X, Young HA, Mao Y, Shi X. Chromium(VI)- induced nuclear factor-κB activation in intact cells via free radical reactions. Carcinogenesis 16:2401-2405 (1995).
19. Yen H-T, Chiang L-C, Wen K-H, Chang S-F, Tsai C-C, Yu C-L, Yu H-S. Arsenic induces interleukin-8 expression in cultured keratinocytes. Arch Dermatol Res 288:716-717 (1996).
20. Germolec DR, Spalding J, Yu H-S, Chen GS, Simeonova PP, Humble MC, Bruccoleri A, Boorman GA, Foley JF, Yoshida T, et al. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors. Am J Pathol 153:1775-1785 (1998).
21. Rhim JS, Jay G, Arnstein P, Price FM, Sanford KK, Aaronson SA. Neoplastic transformation of human epidermal keratinocytes by AD12-SV40 and Kirsten sarcoma viruses. Science 227:1250-1252 (1985).
22. Rhim JS, Fujita J, Arnstein P, Aaronson SA. Neoplastic conversion of human keratinocytes by adenovirus 12-SV40 virus and chemical carcinogens. Science 232:385-388 (1986).
23. Yang JH, Thraves P, Dritschilo A, Rhim JS. Neoplastic transformation of immortalized human keratinocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res 52:3478-3482 (1992).
24. Tamhane AC, Dunlop DD, eds. Multiple comparisons of means. In: Statistics and Data Analysis from Elementary to Intermediate. Upper Saddle River, NJ:Prentiss-Hall, 2000;475-476.
25. Glozak MA, Rogers MB. Specific induction of apoptosis in P19 embryonal carcinoma cells by retinoic acid and BMP2 or BMP4. Dev Biol 179:458-470 (1996).
26. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick Wang EA. Novel regulators of bone formation: molecular clones and activities. Science 242:1528-1537 (1988).
27. Sack GH Jr. Human cell transformation by simian virus 40. In Vitro 17:1-19 (1981).
28. Rhim JS. Development of human cell lines from multiple organs. Ann NY Acad Sci 919:16-25 (2000).
29. Rundell K, Parakati R. The role of the SV40 ST antigen in cell growth promotion and transformation. Semin Cancer Biol 11:5-13 (2001).
30. Steinberg ML, Defendi V. Transformation and immortalization of human keratinocytes by SV40. J Invest Dermatol 81:131s-136s (1983).
31. Wilkinson MG, Millar JBA. Control of the eukaryotic cell cycle by MAP kinase signaling pathways. FASEB J 14:2147-2157 (2000).
32. Parsons R. Phosphatases and tumorigenesis. Curr Opin Oncol 10:88-91 (1998).
33. Pott WA, Benjamin SA, Yang RS. Antagonistic interactions of an arsenic-containing mixture in a multiple organ carcinognecity bioassay. Cancer Lett 133:185-190 (1998).
34. Pott WA, Benjamin SA, Yang RSH. Arsenic, alone and in chemical mixtures, antagonizes the development of glutathione S-transferase π (GST-P) positive foci in the rat liver. Toxicologist 54:135 (2000).
35. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, Corso D, DeBlasio A, Gabrilove J, Scheinberg DA, et al. Complete remission after treatment of acute promyeolocytic leukemia with arsenic trioxide [see comments]. N Engl J Med 339:1341-1348 (1998).
36. Zhang W, Ohnishi K, Shigeno K, Fujisawa S, Naito K, Nakamura S, Takeshita K, Takeshita A, Ohno R. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Leukemia 12:1383-1391 (1998).
37. Jan KY, Huang RY, Lee T-C. Different modes of action of sodium arsenite, 3-aminobenzamide and caffeine on the enhancement of ethyl methanesulfonate clastogenicity. Cytogenet Cell Genet 41:202-208 (1986).
38. Lee T-C, Huang RY, Jan KY. Sodium arsenite enhances the cytotoxicity, clastogenicity, and 6-thioguanine resistant mutagenicity of ultraviolet light in Chinese hamster ovary cells. Mutat Res 148:83-89 (1985).
39. Lee T-C, Wang-Wuu S, Huang RY, Lee KCC, Jan KY. Differential effects of pre- and posttreatment of sodium arsenite on the genotoxicity of methyl methanesulfonate in Chineses hamster ovary cells. Cancer Res 46:1854-1857 (1986).
40. Li JH, Rossman TG. Mechanism of comutagenesis of sodium arsenite with N-methyl-N-nitrosourea. Biol Trace Elem Res 21:381 (1989).
41. Li JH, Rossman TG. Comutagenesis of sodium arsenite with ultraviolet radiation in Chinese hamster V79 cells. Biol Metals 4:197-200 (1991).
42. Okui T, Fujiwara Y. Inhibation of human excision repair by inorganic arsenic and the co-mutagenic effect in V79 Chinese hamster cells. Mutat Res 172:69-76 (1986).
43. Wiencke JK, Yager JW. Specificity of arsenite in potentiating cytogenetic damage induced by the DNA crosslinking agent diepoxybutane. Environ Mol Mutagen 19:195-200(1992).
44. Wiencke JK, Yager JW, Varkonyi A, Hutner M, Lutze LH. Study of arsenic mutagenesis using the plasmid shuttle vector pZ189 propagated in DNA repair proficient human cells. Mutat Res 38:335-344(1993).
45. Simeonova PP, Wang S, Kashon ML, Kommineni C, Crecelius E, Luster MI. Quantitative relationship between arsenic exposure and AP-1 activity in mouse urinary bladder epithelium. Toxicol Sci 60:279-284 (2001).
46. Simeonova PP, Wang S, Toriuma W, Kommineni V, Matheson J, Unimye N, Kayama F, Harki D, Ding M, Vallyathan V, et al. Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation. Cancer Res 60:3445-3453 (2000).
47. Gennings C, Carter WH Jr, Campaign JA, Bae DS, Yang RSH. Statistical analysis of interactive cytotoxicity in human epidermal keratinocytes following exposure to a mixture of four metals. J Agric Biol Environ Stat 7:58-73 (2002).